Healthcare Sector: Value Investing Analysis
About the Healthcare Sector
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
The Healthcare sector groups related businesses that share similar economic characteristics, market dynamics, and competitive forces. By analyzing stocks within this sector, you can compare companies on a more level playing field—making it easier to identify which businesses offer the best value for your investment dollars.
Understanding sector performance helps you evaluate whether individual stocks are cheap or expensive relative to their peers. A P/E ratio that looks high in one sector might be a bargain in another. This context is essential for value investors seeking to calculate realistic expected returns.
Healthcare Stocks: Value Analysis
Below are the stocks we track in the Healthcare sector, with key value investing metrics. If you have special knowledge about this sector, you have an advantage—use these metrics to find stocks that may be trading below their intrinsic value.
| Company | Current Price | Current Price Discount 10 years |
|---|---|---|
| Calithera Biosciences (CALA) |
$0.00 | none |
| Genetic Technologies Limited (GENE) |
$0.00 | none |
| Edge Therapeutics (EDGE) |
$51.65 | none |
| Ironwood Pharmaceuticals (IRWD) |
$4.32 | none |
| Cerus Corporation (CERS) |
$2.35 | none |
| OrganiGram Holdings (OGI) |
$0.99 | none |
| Syros Pharmaceuticals (SYRS) |
$0.00 | none |
| Bayer Aktiengesellschaft (BAYRY) |
$14.45 | none |
| Trinity Biotech plc (TRIB) |
$12.43 | none |
| Xencor (XNCR) |
$20.81 | none |
| BG Medicine (BGMD) |
$0.00 | none |
| BioLife Solutions (BLFS) |
$34.66 | none |
| InspireMD (NSPR) |
$0.74 | none |
| Novo Nordisk A/S (NVO) |
$47.26 | none |
| Tilray (TLRY) |
$4.57 | none |
| Anavex Life Sciences Corp. (AVXL) |
$3.34 | none |
| Rubius Therapeutics (RUBY) |
$0.00 | none |
| Editas Medicine (EDIT) |
$2.88 | none |
| Inovio Pharmaceuticals (INO) |
$0.67 | none |
| Ocuphire Pharma (OCUP) |
$0.00 | none |
| Pulse Biosciences (PLSE) |
$42.41 | none |
| Inspire Medical Systems (INSP) |
$60.16 | none |
| Alkermes plc (ALKS) |
$49.17 | none |
| Globus Medical (GMED) |
$82.35 | none |
| MiMedx Group (MDXG) |
$4.34 | none |
| Biogen (BIIB) |
$207.94 | none |
| Charles River Laboratories International (CRL) |
$267.49 | none |
| Ocular Therapeutix (OCUL) |
$9.19 | none |
| Sorrento Therapeutics (SRNE) |
$0.00 | none |
| Baxter International (BAX) |
$27.55 | 1.5% |
| Utah Medical Products (UTMD) |
$70.83 | none |
| Teva Pharmaceutical Industries Limited (TEVA) |
$35.36 | none |
| Flexion Therapeutics (FLXN) |
$24.91 | none |
| Novartis AG (NVS) |
$154.21 | none |
| Cadence Pharmaceuticals (CADX) |
$0.00 | none |
| Integer Holdings Corporation (ITGR) |
$125.27 | none |
| Veru (VERU) |
$2.31 | none |
(NUS ) |
$5.19 | 86.2% |
| Axsome Therapeutics (AXSM) |
$212.74 | none |
(ONTY) |
$0.00 | none |
| Rocky Mountain Dental Services Holdings, LLC (BDMS) |
$0.00 | 70% |
| EDAP TMS S.A. (EDAP) |
$4.32 | none |
| Deciphera Pharmaceuticals (DCPH) |
$0.00 | none |
| Adamis Pharmaceuticals Corporation (ADMP) |
$0.00 | none |
(SNTS) |
$0.00 | none |
(BMTI) |
$0.00 | none |
| West Pharmaceutical Services (WST) |
$348.60 | none |
| Marinus Pharmaceuticals (MRNS) |
$0.00 | none |
(BLTI) |
$0.00 | none |
| Heron Therapeutics (HRTX) |
$0.49 | none |
| ICU Medical (ICUI) |
$184.56 | none |
| Aethlon Medical (AEMD) |
$3.15 | none |
| KalVista Pharmaceuticals (KALV) |
$27.00 | none |
| LifeVantage Corporation (LFVN) |
$6.76 | none |
| 3M Company (MMM) |
$182.90 | none |
| Lantheus Holdings (LNTH) |
$100.95 | none |
| HCA Healthcare (HCA) |
$413.36 | none |
| DBV Technologies S.A. (DBVT) |
$13.48 | none |
| Rocket Pharmaceuticals (RCKT) |
$3.61 | none |
| Viatris (VTRS) |
$16.43 | none |
| DexCom (DXCM) |
$84.75 | none |
| Alkermes plc ( ALKS) |
$49.17 | none |
(ALTH) |
$0.00 | none |
| Perrigo Company plc (PRGO) |
$12.84 | none |
| Atossa Therapeutics (ATOS) |
$2.36 | none |
| TherapeuticsMD (TXMD) |
$2.07 | none |
| Ionis Pharmaceuticals (IONS) |
$56.56 | none |
| Catalyst Pharmaceuticals (CPRX) |
$31.49 | none |
| Ultragenyx Pharmaceutical (RARE) |
$25.91 | none |
| Iovance Biotherapeutics (IOVA) |
$6.34 | none |
| Arrowhead Pharmaceuticals (ARWR) |
$87.65 | none |
| Jaguar Health (JAGX) |
$0.95 | none |
| Amarin Corporation plc (AMRN) |
$14.36 | none |
| Mannatech, Incorporated (MTEX) |
$4.79 | none |
| Corbus Pharmaceuticals Holdings (CRBP) |
$10.17 | none |
| Krystal Biotech (KRYS) |
$326.45 | none |
| Teladoc Health (TDOC) |
$7.13 | none |
| STERIS plc (STE) |
$237.47 | none |
| Boston Scientific Corporation (BSX) |
$49.31 | none |
| Smith & Nephew plc (SNN) |
$30.11 | none |
| Alcon (ALC) |
$71.81 | none |
| Savara (SVRA) |
$5.83 | none |
| Avinger (AVGR) |
$0.00 | none |
| Tactile Systems Technology (TCMD) |
$29.50 | none |
| American Shared Hospital Services (AMS) |
$1.49 | 45.0% |
(NBS) |
$0.00 | none |
| Imprimis Pharmaceuticals (IMMY) |
$0.00 | none |
| Aurinia Pharmaceuticals (AUPH) |
$15.85 | none |
| AdvisorShares Vice ETF (ACT) |
$48.96 | none |
| Johnson & Johnson (JNJ) |
$259.24 | none |
| Accuray Incorporated (ARAY) |
$0.28 | none |
| Intellia Therapeutics (NTLA) |
$11.94 | none |
| Zimmer Biomet Holdings (ZBH) |
$96.55 | none |
| Amylin Pharmaceuticals (AMLN) |
$0.00 | none |
| Abeona Therapeutics (ABEO) |
$7.24 | none |
(EGRX ) |
$0.25 | none |
| BioLineRx Ltd. (BLRX) |
$2.71 | none |
| SIGA Technologies (SIGA) |
$3.05 | none |
| Theravance Biopharma (TBPH) |
$16.93 | none |
| China Pharma Holdings (CPHI) |
$1.13 | none |
| ImmuCell Corporation (ICCC) |
$11.00 | none |
| Supernus Pharmaceuticals (SUPN) |
$47.64 | none |
| Rennova Health (RNVA) |
$0.00 | none |
| Bristol-Myers Squibb Company (BMY) |
$64.72 | none |
| Fresenius Medical Care AG & Co. KGaA (FMS) |
$24.27 | none |
| Universal Health Services (UHS) |
$173.54 | none |
| Global X Genomics & Biotechnology ETF (GNOM) |
$58.17 | none |
| Nevro Corp. (NVRO) |
$0.00 | none |
| NeoGenomics (NEO) |
$16.57 | none |
| Cara Therapeutics (CARA) |
$0.00 | none |
| Selecta Biosciences (SELB) |
$0.00 | none |
| Medpace Holdings (MEDP) |
$590.67 | none |
| Surgery Partners (SGRY) |
$15.53 | none |
| UFP Technologies (UFPT) |
$314.01 | none |
| Agios Pharmaceuticals (AGIO) |
$30.02 | none |
| Phibro Animal Health Corporation (PAHC) |
$36.33 | none |
| Cumberland Pharmaceuticals (CPIX) |
$6.68 | none |
| Tenet Healthcare Corporation (THC) |
$257.62 | none |
(ABBV ) |
$250.94 | none |
| Amgen (AMGN) |
$387.64 | none |
| Quest Diagnostics Incorporated (DGX) |
$235.22 | none |
| Escalon Medical Corp. (ESMC) |
$0.18 | none |
| Allogene Therapeutics (ALLO) |
$1.88 | none |
| REGENXBIO (RGNX) |
$9.69 | none |
| Atara Biotherapeutics (ATRA) |
$8.38 | none |
| Butterfly Network (BFLY) |
$7.11 | none |
| Lineage Cell Therapeutics (BTX) |
$8.52 | none |
| Celldex Therapeutics (CLDX) |
$41.06 | none |
| Edwards Lifesciences Corporation (EW) |
$85.76 | none |
| DENTSPLY SIRONA (XRAY) |
$14.20 | 54.7% |
| Intuitive Surgical (ISRG) |
$353.10 | none |
| McKesson Corporation (MCK) |
$888.56 | none |
| Alnylam Pharmaceuticals (ALNY) |
$286.62 | none |
| Alphatec Holdings (ATEC) |
$10.15 | none |
| Alimera Sciences (ALIM) |
$0.00 | none |
| Pfizer (PFE) |
$25.15 | 4.9% |
| BioTelemetry (BEAT) |
$0.49 | none |
| Acura Pharmaceuticals (ACUR) |
$0.00 | none |
| Abbott Laboratories (ABT) |
$108.00 | none |
| Patterson Companies (PDCO) |
$0.00 | none |
| Anthera Pharmaceuticals (ANTH) |
$0.00 | none |
| Atrion Corporation (ATRI) |
$0.00 | none |
| Ampio Pharmaceuticals (AMPE) |
$0.18 | none |
| DaVita (DVA) |
$240.96 | none |
| Acorda Therapeutics (ACOR) |
$0.00 | none |
| Affymax (AFFY) |
$0.00 | none |
How to Invest in Healthcare Stocks
Sector-Specific Considerations
When evaluating Healthcare companies, consider these key factors:
- Sector fundamentals: Is this sector growing, mature, or declining? Growth prospects affect reasonable earnings forecasts.
- Economic sensitivity: How does this sector perform in different economic conditions? Understanding cyclicality helps you time purchases.
- Competitive dynamics: Are barriers to entry high or low? Strong moats protect profits and justify premium valuations.
- Regulatory environment: Does government policy significantly impact this sector? Regulatory changes can create risks or opportunities.
- Capital intensity: Does the business require heavy capital investment? Capital-light businesses often generate better returns.
✓ Sector Analysis Checklist
- Compare P/E ratios within the sector
- Look for strong free cash flow generation
- Assess debt levels relative to peers
- Evaluate dividend sustainability
- Check management track record
- Calculate margin of safety
Common Sector Pitfalls
- Chasing last year's hot sector
- Ignoring sector-wide headwinds
- Overpaying for market leaders
- Neglecting competitive threats
- Failing to diversify across sectors
- Not understanding the business model